Targeting LOXL2 and Cardiac Fibrosis for Post-acute Heart Failure Treatment- A Prospective Study
Chang Gung Memorial Hospital
130 participants
Aug 25, 2022
OBSERVATIONAL
Conditions
Summary
A previous study demonstrated that a multidisciplinary cardiac rehabilitation (CR) program was associated with reduced medium- to long-term all-cause mortality in a retrospective propensity score-matched study. The investigators will further investigate the predictors including LOXl2, cardiac MRI, and endothelial function that will benefit from a successful CR.
Eligibility
Inclusion Criteria4
- Patients must give written informed consent before any assessment is performed.
- Inpatients \>= 20 years of age, male or female.
- Patients with a diagnosis of heart failure New York Heart Association (NYHA) class II-IV with BNP \>=100 pg/mL or NT-porBNP \>= 400 pg/mL ( \>= 900 pg/mL if concomitant atrial fibrillation)
- Left ventricular ejection fraction \<= 40% by echocardiography or other methods
Exclusion Criteria8
- Estimated survival time \< 6 months
- Long-term bedridden for more than 3 months
- Cannot tolerate exercise test due to muscular skeletal disorder.
- Cannot cooperate all functional studies
- Ventilator dependent
- Terminal heart status
- Family rejects to participate in this project
- Primary severe valvular heart disease
Interventions
The types of exercise are treadmill walking/walking-jogging/jogging, ergometer cycling, stair climbing, or elliptical machine training. The training intensity is gradually increased fortnightly to reach the targeted Borg's rate of perceived exertion (RPE) of 12-14. The training duration is 40 minutes, which included 5-10 minutes of warm-up and cool-down exercises. The training frequency is three sessions per week, with 36 sessions concluding a complete course.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05498584